image
Healthcare - Biotechnology - NASDAQ - US
$ 3.95
-0.754 %
$ 33.3 M
Market Cap
-0.48
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
57.83%
EBIT Estimate
--6.51%
Net Income Estimate
41.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Curis, Inc.
image
CRIS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart CRIS

image
EBIT FORECAST

EBIT Forecast Chart CRIS

image
NET INCOME FORECAST

Net Income Chart CRIS

image